Abstract
Testing and isolation of cases is an important component of our strategies to fight SARS-CoV-2. In this work, we consider a compartmental model for COVID-19 including a nonlinear term representing symptom-based testing. We analyze how the considered clinical spectrum of symptoms and the testing rate affect the outcome and the severity of the outbreak.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was done in the framework of the Hungarian National Development, Research, and Innovation (NKFIH) Fund 2020-2.1.1-ED-2020-00003 and of the grants TUDFO/47138-1/2019-ITM and EFOP-3.6.2-16-2017-00015. Some authors were also supported by NKFIH KKP 129877 (J.K.), NKFIH FK 124016 (T.T.), Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (F.B.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
There was no necessity for such approval.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data used is properly cited.
